Starke 2011.
Methods | Randomised clinical trial, Switzerland | |
Participants | 134 hospitalised adults at nutritional risk according to NRS‐2002 Male:female = not reported Mean age: 72.5 years |
|
Interventions | Experimental group: Individual nutritional care, including a detailed nutritional assessment, individual food supply, fortification of meals with maltodextrin, rapeseed oil, cream or protein powder or both, in between snacks and oral nutritional supplements (n = 67) Control group: Standard nutritional care, including the prescription of ONSs and nutritional therapy prescribed by the physician independently of this study and according to the routine ward management (n = 67) |
|
Outcomes | Average daily intake, protein intake, changes in body weight, complications, antibiotic therapies, length of hospital stay, quality of life, mortality, compliance, plasma‐concentrations | |
Study dates | Not stated | |
Notes | We contacted the authors on 17th December 2015 by email: remy.meier@ksli.ch. We received no reply. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | The trial was randomised using a computer‐generated randomisation. |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not described |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | The number of participants with incomplete data was not reported. |
Selective reporting (reporting bias) | Low risk | Both all‐cause‐mortality and serious adverse events were reported. |
For‐profit bias | High risk | The trial was funded by Nestlé. |
Other bias | Low risk | The trial appeared to be free of other components that could put it at risk of bias. |